Back

Assessment of long-term safety of pro-angiogenic growth approaches in cardiovascular disease: A systematic review

28 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Emerging pharmacologic strategies in coronary artery disease: anti-inflammatory, antithrombotic, and cardiometabolic approaches Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor David Bates

University of Nottingham, Nottingham (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Leukotriene receptor antagonists and lower risk of major adverse cardiovascular events in patients with asthma
Assistant Professor J. Le Van (Montreal, CA)
Abstract Slides
Presentation thumbnail
A pharmacodynamic analysis of genotype-guided P2Y12-inhibitor monotherapy or dual antiplatelet therapy after PCI in patients with chronic coronary syndrome – the POPular STRATEGY study
Miss Q. Van De Pol (Nieuwegein, NL)
Abstract Slides
Presentation thumbnail
Anti-inflammatory effects of atorvastatin and colchicine combination in patients with acute or chronic coronary syndrome undergoing coronary angiography and/or PCI
Mr T. Trijitwatthanakoon (Bangkok, TH)
Abstract Slides
Presentation thumbnail
Empagliflozin attenuates coronary atherosclerosis by promoting the differentiation of pericoronary adipose-derived stem cells
Mr S. Shi (Nanjing, CN)
Abstract Slides
Presentation thumbnail
Colchicine serum levels in patients with chronic coronary syndrome
Miss J. Jannink (Utrecht, NL)
Abstract Slides

Access the full session

Session thumbnail
Emerging pharmacologic strategies in coronary artery disease: anti-inflammatory, antithrombotic, and cardiometabolic approaches

The Event

Event poster

ESC Congress 2026

28 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic role of advanced retinopathy of vascular etiology in coronary artery disease in very long-term follow-up.
7 April 2022
thumbnail
Congress Presentation
Safety and efficacy of zodasiran, a hepatic sirna targeting angptl3, in mixed hyperlipidemia patients: 2 year open label extension (OLE) results from ARCHES-2
31 August 2025
thumbnail
Congress Presentation
Effects of endocardial bFGF administration using an electrode-equipped catheter in a porcine model of myocardial infarction
1 September 2025
thumbnail
Congress Presentation
Sacubitril/Valsartan and cardiovascular outcomes in cancer patients on anthracycline therapy: a global health research network retrospective analysis
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources